• Stress Fiber Anisotropy Regulates Force-Dependent Gene Expre

  2026-06-04

  This study demonstrates that the orientation of actin stress fibers in living cells determines how different mechanical force modes drive chromatin stretching and upregulation of gene transcription. By using advanced 3D magnetic twisting cytometry and myosin II inhibition, the authors reveal a direct mechanistic link between cytoskeletal anisotropy and force-dependent nuclear responses.

• Phosbind Acrylamide: High-Resolution Protein Phosphorylation

  2026-06-03

  Phosbind Acrylamide from APExBIO streamlines antibody-free detection of protein phosphorylation states in SDS-PAGE workflows. This specialized phosphate-binding reagent delivers enhanced resolution for signaling studies, reducing troubleshooting and boosting reproducibility in complex post-translational modification research.

• Solving Assay Challenges with Bromodomain Inhibitor, (+)-JQ1

  2026-06-03

  This article addresses key laboratory challenges in cell viability and apoptosis assays, demonstrating how Bromodomain Inhibitor, (+)-JQ1 (SKU A1910) from APExBIO supports reproducible, mechanistically clear results. Practical scenarios and literature-backed protocols help researchers optimize BET inhibition for cancer, inflammation, and fertility studies.

• Panobinostat (LBH589): Optimizing Apoptosis and Epigenetic A

  2026-06-02

  Panobinostat (LBH589) empowers advanced oncology research by enabling precise control over apoptosis and epigenetic modulation, even in drug-resistant cancer models. Discover optimized workflows, key troubleshooting strategies, and the latest reference-backed insights that set Panobinostat apart as a versatile research tool.

• Pifithrin-α (PFTα): Precision p53 Inhibition in Environmenta

  2026-06-02

  Explore how Pifithrin-α, a leading p53 inhibitor, is transforming environmental neurotoxicity research by enabling targeted analysis of ferroptosis and memory impairment mechanisms. This article offers advanced protocol guidance and highlights unique insights for neuroscience and toxicology studies.

• Tris(2-carboxyethyl) Phosphine Hydrochloride in Advanced Ass

  2026-06-01

  Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein analysis workflows with its robust, odorless reduction of disulfide bonds and versatile compatibility in sensitive assay formats. Unlock superior protein digestion, innovative lateral flow assay architectures, and reliable redox manipulations with this next-generation reducing agent.

• Mubritinib Reveals OXPHOS Dependency in Chemoresistant AML

  2026-06-01

  Baccelli et al. (2019) identify Mubritinib as a potent, selective inhibitor of mitochondrial complex I, demonstrating strong anti-leukemic activity in chemotherapy-resistant acute myeloid leukemia (AML) with oxidative phosphorylation (OXPHOS) hyperactivity. This work uncovers a metabolic vulnerability in poor-outcome AML and supports repurposing mitochondrial ETC inhibitors for targeted therapy.

• Mubritinib (TAK 165): Redefining Mitochondrial Targeting in

  2026-05-31

  This article offers a thought-leadership perspective on Mubritinib (TAK 165) as an advanced research tool for translational oncology, focusing on its mechanistic targeting of mitochondrial complex I and its evolving role beyond HER2-driven cancer research. Integrating recent evidence and protocol guidance, it provides translational researchers with strategic insights for deploying Mubritinib in models of chemotherapy-resistant leukemia, lymphoma, and lung cancer, while mapping the path for cross-domain innovation.

• BMS 309403 and FABP4: Deep Mechanistic Insights for Atherosc

  2026-05-30

  Explore the advanced mechanism and translational value of BMS 309403 as a potent FABP4 inhibitor. This article uniquely connects molecular insights to assay design for atherosclerosis and metabolic disease research.

• Biotin-16-UTP (SKU B8154): Reliable RNA Labeling for Cell As

  2026-05-29

  Biotin-16-UTP (SKU B8154) from APExBIO streamlines sensitive and reproducible RNA labeling for cell viability, proliferation, and cytotoxicity assays. This article demonstrates, through scenario-driven analysis and evidence-based comparison, how this biotin-labeled uridine triphosphate enables robust RNA detection and purification—addressing real-world laboratory challenges in advanced molecular biology workflows.

• Cy7 NHS Ester: Practical Guide for Near-Infrared Protein Lab

  2026-05-29

  Cy7 NHS ester addresses the need for efficient, water-soluble, near-infrared labeling of proteins and peptides, providing high sensitivity for live cell and in vivo imaging without requiring organic co-solvents. It is especially suitable for labeling biomolecules prone to denaturation. This reagent is not recommended for workflows demanding long-term solution stability or for targets lacking accessible amino groups.

• GLI2 Drives Tumor Immune Evasion via WNT and Prostaglandin P

  2026-05-28

  This study identifies GLI2 as a central regulator of tumor immune evasion and resistance to immunotherapy, acting through coordinated WNT ligand and prostaglandin signaling. The findings highlight new mechanistic targets for overcoming immune checkpoint blockade resistance and inform rational combination strategies in cancer immunotherapy.

• CK2 and ERK8 Inhibitor: Advancing Phase Separation Research

  2026-05-28

  Explore how the small molecule inhibitor 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid powers next-generation studies of protein phase separation and kinase pathways. This article reveals unique strategies and insights for leveraging this biochemical reagent in cutting-edge research.

• Vemurafenib (PLX4032) in Melanoma: Protocols, Resistance, an

  2026-05-27

  Vemurafenib (PLX4032) is a gold-standard BRAF V600E inhibitor, driving breakthroughs in melanoma cell proliferation inhibition and resistance mechanism research. This article delivers actionable workflows, troubleshooting strategies, and the latest multi-omics insights for optimizing experimental outcomes in metastatic melanoma models.

• Direct Mouse Genotyping Kit: Protocol Guidance and QC Best P

  2026-05-27

  The Direct Mouse Genotyping Kit streamlines genotyping workflows by enabling direct PCR amplification from mouse tissue lysates, eliminating the need for separate genomic DNA purification. This kit is well suited for routine and high-throughput genotyping in biomedical research, but should not be used where ultra-pure DNA or downstream enzymatic applications beyond PCR are required.

454 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page